Navigation Links
National Pharmaceutical Company to Sponsor Popular Indianapolis Walk
Date:6/12/2008

Salix teams up with Crohn's & Colitis Foundation of America for this year's

Take Steps event

KANSAS CITY, Mo., June 12 /PRNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) is happy to announce that Salix Pharmaceuticals, a leader in gastroenterology, is a major sponsor of this year's Take Steps event on June 14th at 4 p.m. starting with family festivities in Overland Park, Kansas a suburb of Kansas City. The 5K walk begins after the festivities at 7 PM and takes place at Corporate Woods Office Park and is expected to draw hundreds of participants who will carry noisemakers to break the silence when it comes to Crohn's disease and ulcerative colitis.

While Takes Steps for Crohn's & Colitis events are taking place in dozen of cities around the country this year, Salix has selected Kansas City as one of only four markets in which to be a major sponsor.

"We work closely with the CCFA to support its overall mission nationwide. In addition, CCFA conducts many local, awareness-building events around the country and we have chosen Kansas City as a pilot market for supporting CCFA's local activities," says Mike Freeman, Executive Director, Investor Relations & Corporate Communications. "We want patients in Indianapolis to know that they have a choice in bowel preparations and may not necessarily have to drink large amounts of unpleasant-tasting liquids when they prepare for their colonoscopies."

Approximately 70,000 people in the Kansas City Metro area and nearly 1.5 million Americans have Crohn's disease or ulcerative colitis. More than 83 cents of every dollar raised from Take Steps directly supports The Crohn's & Colitis Foundation's research, education and support initiatives. This event, however, not only raises money for Crohn's disease and colitis research, but it also brings about awareness of these two painful and unpredictable afflictions.

Andi Harrington, development manager for the Mid-America Chapter of the Crohn's & Colitis Foundation of America, is thrilled to have a national pharmaceutical company taking part in this year's event. "To have Salix sponsor the local Take Steps event and choose Kansas City is a great honor for us and the city. We're happy to be partnering with a company that develops and provides innovative treatment options for patients with inflammatory bowel disease that undergo colonoscopies on a regular basis."

Take Steps for Crohn's & Colitis is the nation's largest event dedicated to finding cures for digestive diseases. Participants raise money for crucial research that wouldn't even have been possible a few short years ago, bringing us closer to a future free from Crohn's disease and ulcerative colitis. Beyond raising money for research, Take Steps brings together the Crohn's and colitis community in a fun and energetic atmosphere. Participants are encouraged to make noise and be heard -- raising awareness of these little -- known diseases in their community and across the nation.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix markets COLAZAL(R) (balsalazide disodium) Capsules 750 mg, XIFAXAN(R) (rifaximin) tablets 200 mg , OSMOPREP(R) (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets, MOVIPREP(R) (PEG 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate and Ascorbic Acid for Oral Solution), VISICOL(R) (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) Tablets, PEPCID(R) (famotidine) for Oral Suspension, Oral Suspension DIURIL(R) (Chlorothiazide), AZASAN(R) Azathioprine Tablets, USP, 75/100 mg , ANUSOL-HC(R) 2.5% (Hydrocortisone Cream, USP), ANUSOL-HC(R) 25 mg Suppository (Hydrocortisone Acetate), PROCTOCORT(R) Cream (Hydrocortisone Cream, USP) 1% and PROCTOCORT(R) Suppository (Hydrocortisone Acetate Rectal Suppositories) 30 mg. Vapreotide acetate, balsalazide tablet, granulated mesalamine and XIFAXAN(R) for additional indications are under development.


'/>"/>
SOURCE Salix Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... More than ... so it is not surprising that bariatric surgery has received increased attention in recent ... explains. Of course, when it comes to weight loss, most people are familiar with ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon Blue Cross Blue ... Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their fields ... Director of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... An influential ... for a third time to shed lights on the variety of topics detailing why ... stories, “Nurse Appreciation” tackles why this career has gone from being in a major ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... the factors of a stroke, which we as a society can control and change. ... a stroke occurs nearly every 40 seconds within the United States. Plus, with an ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response to ... who are unaware of the plight of aphasia. In collaboration with the American ... Awareness” campaign. , The link between stroke and aphasia is relatively unknown, but ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... HILDEN , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... into a licensing and co-development agreement with Therawis Diagnostics GmbH ... project will be to develop and market PITX2 as a ... and other high-risk breast cancer patients. "We are ...
(Date:5/25/2016)... NORTH CHESTERFIELD, Va. , May 25, 2016 ... commercially-available next-generation sequencing test for wounds and infections. ... fungi, ALL parasites, and select viruses. The test ... infected area. David G. ... advanced molecular testing to facilitate wound healing: "We ...
(Date:5/24/2016)... , May 24, 2016 ... den Markt gebracht, die es Ärzten erlaubt, ihre ... zu behandeln: MDLinking kombiniert Live Streaming mit einer ... Umfeld zu kommunizieren. Mediziner in Europa, Afrika, Asien ... sich bereits für die Plattform registriert. ...
Breaking Medicine Technology: